VedaBio Analysis
What is VedaBio?
VedaBio is a biotechnology company specializing in ultra-rapid molecular detection using its CRISPR Cascade™ platform for accurate results without target amplification.
Employees
30
Founded
2021
Company Stage
Series A
YC Batch
S21
Product Features & Capabilities
- Ultra-rapid molecular detection, CRISPR Cascade™ platform, target amplification-free detection, massive multiplexing capability, rapid reprogramming for new targets.
Who are the founders of VedaBio
AG
Anurup Ganguli
Founder
Investors
- OMX Ventures (lead investor)
- Other undisclosed investors contributing to the initial funding of over $40 million
See something that needs updating? Suggest edits to this profile.